EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Evaluation of Urine Exosome Lecithin Cholesterol Acyltransferase as a Biomarker for Diabetes Diagnosis and Dyslipidemia

Tianci Liu, Na Liu, Qian Meng, Tao Li, Man Zhang iD

Diabetes/Metabolism Research and Reviews · 2026-03 · 42 (3)

DOI: 10.1002/dmrr.70133 ↗

At a glance

Journal article in Diabetes/Metabolism Research and Reviews, published online on 2026-03-03. Written by Tianci Liu and 4 co-authors. Institution: Clinical Laboratory Medicine, Beijing Shijitan Hospital, Capital Medical University, Beijing, China. Major MEDLINE topics: Biomarkers, Exosomes, Phosphatidylcholine-Sterol O-Acyltransferase, Dyslipidemias. 30 references. The full text is freely available (open access, CC BY 4.0). Funded by: Validation and application development of a new urine diagnostic and monitoring marker test in type 2 diabetes-related diseases, Capital Medical University Scientific Research Development Fund, The Beijing High-Level Innovation and Entrepreneurship Talent Support Program (Young Top Talent Projects).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Aims

Given the necessity for diabetes monitoring, investigating the expression of lipid metabolism‐related proteins may provide valuable insights for disease surveillance and mechanistic elucidation. Materials and Methods LC‐MS/MS was used to analyse the expression of lipid metabolism‐related proteins in urine exosomes. Biomarkers were screened and their clinical significance was evaluated. Insulin‐resistant hepatocytes and diabetic mouse models were established to validate and explore the underlying mechanisms.

Results

Logistic regression analysis revealed that elevated triglyceride (TG) and reduced high‐density lipoprotein cholesterol (HDL‐C) were independent risk factors for diabetes. In normal controls and those with prediabetes, females had higher total cholesterol (TC) and HDL‐C but lower TG compared to males, whereas no gender differences were observed in the diabetic group. 29 lipid metabolism‐related proteins were screened by proteomics, among which lecithin cholesterol acyltransferase (LCAT) was the target protein. Disordered lipid metabolism and upregulation of LCAT were observed in diabetic patients, insulin‐resistant cells, and diabetic mice. The liver may be a key organ of early diabetic injury, as evidenced by disorganised hepatocyte arrangement and compensatory LCAT production during the prediabetic stage. As the disease progresses to diabetes, hepatic steatosis significantly worsens, accompanied by elevation of serum and urine LCAT. Urine exosome LCAT not only holds diagnostic value but also exhibits distinctive dynamic changes: an early rise in diabetes followed by a decline during periods of poor glycaemic control (HbA1c ≥ 8% or FBG > 7.8 mmol/L).

Conclusions

LCAT, a critical regulator of lipid metabolism, could serve as a novel biomarker for detection and monitoring of diabetes.

Subjects

MeSH terms (MEDLINE)

BiomarkersExosomesPhosphatidylcholine-Sterol O-AcyltransferaseDyslipidemiasDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2AnimalsFemaleMaleMiceHumansMice, Inbred C57BLInsulin ResistancePrognosisMiddle AgedLipid MetabolismCase-Control Studies

Author keywords

LCATanimal modelbiomarkerscell modeldiabetes mellituslipid metabolism

Substances

BiomarkersPhosphatidylcholine-Sterol O-Acyltransferase

Authors and institutions

  • Clinical Laboratory Medicine, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
  • Beijing Key Laboratory of Urinary Cellular Molecular Diagnostics, Beijing, China.
  • Institute of Regenerative Medicine and Laboratory Technology Innovation, Qingdao University, Qingdao, China.

ORCID profiles: Man Zhang

Funding

  • Validation and application development of a new urine diagnostic and monitoring marker test in type 2 diabetes-related diseases
  • Capital Medical University Scientific Research Development Fund
  • The Beijing High-Level Innovation and Entrepreneurship Talent Support Program (Young Top Talent Projects)

Cite

APA

Liu, T., Liu, N., Meng, Q., Li, T., & Zhang, M. (2026). Evaluation of Urine Exosome Lecithin Cholesterol Acyltransferase as a Biomarker for Diabetes Diagnosis and Dyslipidemia. Diabetes/Metabolism Research and Reviews, 42(3). https://doi.org/10.1002/dmrr.70133

Vancouver

Liu T, Liu N, Meng Q, Li T, Zhang M. Evaluation of Urine Exosome Lecithin Cholesterol Acyltransferase as a Biomarker for Diabetes Diagnosis and Dyslipidemia. Diabetes/Metabolism Research and Reviews. 2026;42(3). doi:10.1002/dmrr.70133

BibTeX
@article{Liu2026,
  author = {Liu, Tianci and Liu, Na and Meng, Qian and Li, Tao and Zhang, Man},
  title = {Evaluation of Urine Exosome Lecithin Cholesterol Acyltransferase as a Biomarker for Diabetes Diagnosis and Dyslipidemia},
  journal = {Diabetes/Metabolism Research and Reviews},
  year = {2026},
  volume = {42},
  number = {3},
  doi = {10.1002/dmrr.70133}
}
Start for free →